Source: PR Newswire

Press Release: RadiaDyn : RadiaDyne's OARtrac Technology Named To R&D 100 Award Finalists List

HOUSTON, Aug. 23, 2018 /PRNewswire/ -- RadiaDyne®, the innovator of real-time, in vivo, diagnostic radiation patient dose monitoring technology for cancer treatment, and the exclusive manufacturer of the OARtrac® radiation dose monitoring system, was honored to be selected as a finalist...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Isham's photo - Founder & CEO of RadiaDyn

Founder & CEO

John Isham

CEO Approval Rating

81/100

Read more